CRCT · 264 older adults
TORC1 inhibition enhances immune function and reduces infections in the elderly
J Mannick, M Morris, H Hockey, G Roma, M Beibel, K Kulmatycki et al.. Science Translational Medicine. 2018.
- In plain language
- Low-dose TORC1 inhibition was associated with fewer reported infections over a year.
- Limits
- A later phase 3 trial missed its primary endpoint.
- Source
- doi.org/10.1126/scitranslmed.aaq1564 · PubMed 29997249
Summary written by Everstack from the published abstract. Verified against Crossref on 2026-10-15. The authors do not endorse Everstack.